nodes	percent_of_prediction	percent_of_DWPC	metapath
Rimantadine—Rigors—Doxorubicin—urinary bladder cancer	0.00471	0.00471	CcSEcCtD
Rimantadine—Vomiting—Mitomycin—urinary bladder cancer	0.00466	0.00466	CcSEcCtD
Rimantadine—Stomatitis—Fluorouracil—urinary bladder cancer	0.00466	0.00466	CcSEcCtD
Rimantadine—Dysphagia—Etoposide—urinary bladder cancer	0.00465	0.00465	CcSEcCtD
Rimantadine—Chills—Thiotepa—urinary bladder cancer	0.00465	0.00465	CcSEcCtD
Rimantadine—Rash—Mitomycin—urinary bladder cancer	0.00462	0.00462	CcSEcCtD
Rimantadine—Dermatitis—Mitomycin—urinary bladder cancer	0.00462	0.00462	CcSEcCtD
Rimantadine—Headache—Mitomycin—urinary bladder cancer	0.00459	0.00459	CcSEcCtD
Rimantadine—Bronchospasm—Etoposide—urinary bladder cancer	0.00458	0.00458	CcSEcCtD
Rimantadine—Sweating increased—Etoposide—urinary bladder cancer	0.00453	0.00453	CcSEcCtD
Rimantadine—Lacrimation increased—Epirubicin—urinary bladder cancer	0.00451	0.00451	CcSEcCtD
Rimantadine—Tension—Thiotepa—urinary bladder cancer	0.00443	0.00443	CcSEcCtD
Rimantadine—Stomatitis—Cisplatin—urinary bladder cancer	0.00442	0.00442	CcSEcCtD
Rimantadine—Nervousness—Thiotepa—urinary bladder cancer	0.00438	0.00438	CcSEcCtD
Rimantadine—Nausea—Mitomycin—urinary bladder cancer	0.00435	0.00435	CcSEcCtD
Rimantadine—Oedema peripheral—Gemcitabine—urinary bladder cancer	0.0043	0.0043	CcSEcCtD
Rimantadine—Atrioventricular block—Epirubicin—urinary bladder cancer	0.00429	0.00429	CcSEcCtD
Rimantadine—Hypoaesthesia—Fluorouracil—urinary bladder cancer	0.00427	0.00427	CcSEcCtD
Rimantadine—Gait disturbance—Epirubicin—urinary bladder cancer	0.00426	0.00426	CcSEcCtD
Rimantadine—Lacrimation increased—Doxorubicin—urinary bladder cancer	0.00418	0.00418	CcSEcCtD
Rimantadine—Agitation—Thiotepa—urinary bladder cancer	0.00415	0.00415	CcSEcCtD
Rimantadine—Stomatitis—Etoposide—urinary bladder cancer	0.00405	0.00405	CcSEcCtD
Rimantadine—Atrioventricular block—Doxorubicin—urinary bladder cancer	0.00397	0.00397	CcSEcCtD
Rimantadine—Gait disturbance—Doxorubicin—urinary bladder cancer	0.00394	0.00394	CcSEcCtD
Rimantadine—Cough—Thiotepa—urinary bladder cancer	0.00394	0.00394	CcSEcCtD
Rimantadine—Chills—Gemcitabine—urinary bladder cancer	0.00391	0.00391	CcSEcCtD
Rimantadine—Convulsion—Thiotepa—urinary bladder cancer	0.00391	0.00391	CcSEcCtD
Rimantadine—Hypertension—Thiotepa—urinary bladder cancer	0.0039	0.0039	CcSEcCtD
Rimantadine—Anxiety—Thiotepa—urinary bladder cancer	0.00383	0.00383	CcSEcCtD
Rimantadine—Tinnitus—Cisplatin—urinary bladder cancer	0.00379	0.00379	CcSEcCtD
Rimantadine—Confusional state—Thiotepa—urinary bladder cancer	0.00372	0.00372	CcSEcCtD
Rimantadine—Hypoaesthesia—Etoposide—urinary bladder cancer	0.00371	0.00371	CcSEcCtD
Rimantadine—Mental disability—Epirubicin—urinary bladder cancer	0.00361	0.00361	CcSEcCtD
Rimantadine—Tachycardia—Thiotepa—urinary bladder cancer	0.0036	0.0036	CcSEcCtD
Rimantadine—Anorexia—Thiotepa—urinary bladder cancer	0.00351	0.00351	CcSEcCtD
Rimantadine—Eye pain—Epirubicin—urinary bladder cancer	0.00334	0.00334	CcSEcCtD
Rimantadine—Chills—Etoposide—urinary bladder cancer	0.00334	0.00334	CcSEcCtD
Rimantadine—Mental disability—Doxorubicin—urinary bladder cancer	0.00334	0.00334	CcSEcCtD
Rimantadine—Tremor—Cisplatin—urinary bladder cancer	0.00332	0.00332	CcSEcCtD
Rimantadine—Cough—Gemcitabine—urinary bladder cancer	0.00331	0.00331	CcSEcCtD
Rimantadine—Hypertension—Gemcitabine—urinary bladder cancer	0.00328	0.00328	CcSEcCtD
Rimantadine—Somnolence—Thiotepa—urinary bladder cancer	0.00328	0.00328	CcSEcCtD
Rimantadine—Dyspepsia—Thiotepa—urinary bladder cancer	0.00324	0.00324	CcSEcCtD
Rimantadine—Convulsion—Fluorouracil—urinary bladder cancer	0.00324	0.00324	CcSEcCtD
Rimantadine—Decreased appetite—Thiotepa—urinary bladder cancer	0.0032	0.0032	CcSEcCtD
Rimantadine—Gastrointestinal disorder—Thiotepa—urinary bladder cancer	0.00318	0.00318	CcSEcCtD
Rimantadine—Fatigue—Thiotepa—urinary bladder cancer	0.00318	0.00318	CcSEcCtD
Rimantadine—Constipation—Thiotepa—urinary bladder cancer	0.00315	0.00315	CcSEcCtD
Rimantadine—Eye pain—Doxorubicin—urinary bladder cancer	0.00309	0.00309	CcSEcCtD
Rimantadine—Cardiac failure—Epirubicin—urinary bladder cancer	0.00309	0.00309	CcSEcCtD
Rimantadine—Confusional state—Fluorouracil—urinary bladder cancer	0.00307	0.00307	CcSEcCtD
Rimantadine—Convulsion—Cisplatin—urinary bladder cancer	0.00307	0.00307	CcSEcCtD
Rimantadine—Feeling abnormal—Thiotepa—urinary bladder cancer	0.00304	0.00304	CcSEcCtD
Rimantadine—Ataxia—Methotrexate—urinary bladder cancer	0.00303	0.00303	CcSEcCtD
Rimantadine—Gastrointestinal pain—Thiotepa—urinary bladder cancer	0.00301	0.00301	CcSEcCtD
Rimantadine—Anxiety—Cisplatin—urinary bladder cancer	0.003	0.003	CcSEcCtD
Rimantadine—Hyperhidrosis—Gemcitabine—urinary bladder cancer	0.003	0.003	CcSEcCtD
Rimantadine—Tachycardia—Fluorouracil—urinary bladder cancer	0.00297	0.00297	CcSEcCtD
Rimantadine—Anorexia—Gemcitabine—urinary bladder cancer	0.00295	0.00295	CcSEcCtD
Rimantadine—Abdominal pain—Thiotepa—urinary bladder cancer	0.00291	0.00291	CcSEcCtD
Rimantadine—Anorexia—Fluorouracil—urinary bladder cancer	0.00291	0.00291	CcSEcCtD
Rimantadine—Cardiac failure—Doxorubicin—urinary bladder cancer	0.00286	0.00286	CcSEcCtD
Rimantadine—Loss of consciousness—Etoposide—urinary bladder cancer	0.00285	0.00285	CcSEcCtD
Rimantadine—Ataxia—Epirubicin—urinary bladder cancer	0.00284	0.00284	CcSEcCtD
Rimantadine—Cough—Etoposide—urinary bladder cancer	0.00283	0.00283	CcSEcCtD
Rimantadine—Tachycardia—Cisplatin—urinary bladder cancer	0.00282	0.00282	CcSEcCtD
Rimantadine—Convulsion—Etoposide—urinary bladder cancer	0.00281	0.00281	CcSEcCtD
Rimantadine—Insomnia—Gemcitabine—urinary bladder cancer	0.0028	0.0028	CcSEcCtD
Rimantadine—Hypertension—Etoposide—urinary bladder cancer	0.0028	0.0028	CcSEcCtD
Rimantadine—Hyperhidrosis—Cisplatin—urinary bladder cancer	0.00279	0.00279	CcSEcCtD
Rimantadine—Dyspnoea—Gemcitabine—urinary bladder cancer	0.00276	0.00276	CcSEcCtD
Rimantadine—Insomnia—Fluorouracil—urinary bladder cancer	0.00276	0.00276	CcSEcCtD
Rimantadine—Somnolence—Gemcitabine—urinary bladder cancer	0.00276	0.00276	CcSEcCtD
Rimantadine—Anorexia—Cisplatin—urinary bladder cancer	0.00275	0.00275	CcSEcCtD
Rimantadine—Dyspnoea—Fluorouracil—urinary bladder cancer	0.00272	0.00272	CcSEcCtD
Rimantadine—Somnolence—Fluorouracil—urinary bladder cancer	0.00271	0.00271	CcSEcCtD
Rimantadine—Decreased appetite—Gemcitabine—urinary bladder cancer	0.00269	0.00269	CcSEcCtD
Rimantadine—Dyspepsia—Fluorouracil—urinary bladder cancer	0.00268	0.00268	CcSEcCtD
Rimantadine—Gastrointestinal disorder—Gemcitabine—urinary bladder cancer	0.00268	0.00268	CcSEcCtD
Rimantadine—Fatigue—Gemcitabine—urinary bladder cancer	0.00267	0.00267	CcSEcCtD
Rimantadine—Confusional state—Etoposide—urinary bladder cancer	0.00267	0.00267	CcSEcCtD
Rimantadine—Constipation—Gemcitabine—urinary bladder cancer	0.00265	0.00265	CcSEcCtD
Rimantadine—Decreased appetite—Fluorouracil—urinary bladder cancer	0.00265	0.00265	CcSEcCtD
Rimantadine—Asthenia—Thiotepa—urinary bladder cancer	0.00264	0.00264	CcSEcCtD
Rimantadine—Gastrointestinal disorder—Fluorouracil—urinary bladder cancer	0.00263	0.00263	CcSEcCtD
Rimantadine—Ataxia—Doxorubicin—urinary bladder cancer	0.00263	0.00263	CcSEcCtD
Rimantadine—Dysphagia—Epirubicin—urinary bladder cancer	0.00261	0.00261	CcSEcCtD
Rimantadine—Tachycardia—Etoposide—urinary bladder cancer	0.00258	0.00258	CcSEcCtD
Rimantadine—Dyspnoea—Cisplatin—urinary bladder cancer	0.00258	0.00258	CcSEcCtD
Rimantadine—Hyperhidrosis—Etoposide—urinary bladder cancer	0.00256	0.00256	CcSEcCtD
Rimantadine—Feeling abnormal—Gemcitabine—urinary bladder cancer	0.00255	0.00255	CcSEcCtD
Rimantadine—Anorexia—Etoposide—urinary bladder cancer	0.00252	0.00252	CcSEcCtD
Rimantadine—Diarrhoea—Thiotepa—urinary bladder cancer	0.00252	0.00252	CcSEcCtD
Rimantadine—Decreased appetite—Cisplatin—urinary bladder cancer	0.00251	0.00251	CcSEcCtD
Rimantadine—Feeling abnormal—Fluorouracil—urinary bladder cancer	0.00251	0.00251	CcSEcCtD
Rimantadine—Gastrointestinal disorder—Cisplatin—urinary bladder cancer	0.00249	0.00249	CcSEcCtD
Rimantadine—Depression—Methotrexate—urinary bladder cancer	0.00248	0.00248	CcSEcCtD
Rimantadine—Dizziness—Thiotepa—urinary bladder cancer	0.00244	0.00244	CcSEcCtD
Rimantadine—Stomatitis—Methotrexate—urinary bladder cancer	0.00242	0.00242	CcSEcCtD
Rimantadine—Dysphagia—Doxorubicin—urinary bladder cancer	0.00241	0.00241	CcSEcCtD
Rimantadine—Pollakiuria—Epirubicin—urinary bladder cancer	0.00241	0.00241	CcSEcCtD
Rimantadine—Feeling abnormal—Cisplatin—urinary bladder cancer	0.00238	0.00238	CcSEcCtD
Rimantadine—Dyspnoea—Etoposide—urinary bladder cancer	0.00236	0.00236	CcSEcCtD
Rimantadine—Somnolence—Etoposide—urinary bladder cancer	0.00235	0.00235	CcSEcCtD
Rimantadine—Vomiting—Thiotepa—urinary bladder cancer	0.00234	0.00234	CcSEcCtD
Rimantadine—Rash—Thiotepa—urinary bladder cancer	0.00232	0.00232	CcSEcCtD
Rimantadine—Dermatitis—Thiotepa—urinary bladder cancer	0.00232	0.00232	CcSEcCtD
Rimantadine—Headache—Thiotepa—urinary bladder cancer	0.00231	0.00231	CcSEcCtD
Rimantadine—Decreased appetite—Etoposide—urinary bladder cancer	0.0023	0.0023	CcSEcCtD
Rimantadine—Gastrointestinal disorder—Etoposide—urinary bladder cancer	0.00229	0.00229	CcSEcCtD
Rimantadine—Fatigue—Etoposide—urinary bladder cancer	0.00228	0.00228	CcSEcCtD
Rimantadine—Stomatitis—Epirubicin—urinary bladder cancer	0.00227	0.00227	CcSEcCtD
Rimantadine—Constipation—Etoposide—urinary bladder cancer	0.00226	0.00226	CcSEcCtD
Rimantadine—Pollakiuria—Doxorubicin—urinary bladder cancer	0.00223	0.00223	CcSEcCtD
Rimantadine—Asthenia—Gemcitabine—urinary bladder cancer	0.00222	0.00222	CcSEcCtD
Rimantadine—Nausea—Thiotepa—urinary bladder cancer	0.00219	0.00219	CcSEcCtD
Rimantadine—Feeling abnormal—Etoposide—urinary bladder cancer	0.00218	0.00218	CcSEcCtD
Rimantadine—Gastrointestinal pain—Etoposide—urinary bladder cancer	0.00216	0.00216	CcSEcCtD
Rimantadine—Diarrhoea—Gemcitabine—urinary bladder cancer	0.00212	0.00212	CcSEcCtD
Rimantadine—Stomatitis—Doxorubicin—urinary bladder cancer	0.0021	0.0021	CcSEcCtD
Rimantadine—Abdominal pain—Etoposide—urinary bladder cancer	0.00209	0.00209	CcSEcCtD
Rimantadine—Diarrhoea—Fluorouracil—urinary bladder cancer	0.00209	0.00209	CcSEcCtD
Rimantadine—Tinnitus—Methotrexate—urinary bladder cancer	0.00208	0.00208	CcSEcCtD
Rimantadine—Hypoaesthesia—Epirubicin—urinary bladder cancer	0.00208	0.00208	CcSEcCtD
Rimantadine—Asthenia—Cisplatin—urinary bladder cancer	0.00207	0.00207	CcSEcCtD
Rimantadine—Oedema peripheral—Epirubicin—urinary bladder cancer	0.00206	0.00206	CcSEcCtD
Rimantadine—Dizziness—Fluorouracil—urinary bladder cancer	0.00202	0.00202	CcSEcCtD
Rimantadine—Chills—Methotrexate—urinary bladder cancer	0.002	0.002	CcSEcCtD
Rimantadine—Diarrhoea—Cisplatin—urinary bladder cancer	0.00198	0.00198	CcSEcCtD
Rimantadine—Vomiting—Gemcitabine—urinary bladder cancer	0.00197	0.00197	CcSEcCtD
Rimantadine—Rash—Gemcitabine—urinary bladder cancer	0.00195	0.00195	CcSEcCtD
Rimantadine—Dermatitis—Gemcitabine—urinary bladder cancer	0.00195	0.00195	CcSEcCtD
Rimantadine—Tinnitus—Epirubicin—urinary bladder cancer	0.00195	0.00195	CcSEcCtD
Rimantadine—Headache—Gemcitabine—urinary bladder cancer	0.00194	0.00194	CcSEcCtD
Rimantadine—Vomiting—Fluorouracil—urinary bladder cancer	0.00194	0.00194	CcSEcCtD
Rimantadine—Hypoaesthesia—Doxorubicin—urinary bladder cancer	0.00192	0.00192	CcSEcCtD
Rimantadine—Rash—Fluorouracil—urinary bladder cancer	0.00192	0.00192	CcSEcCtD
Rimantadine—Dermatitis—Fluorouracil—urinary bladder cancer	0.00192	0.00192	CcSEcCtD
Rimantadine—Headache—Fluorouracil—urinary bladder cancer	0.00191	0.00191	CcSEcCtD
Rimantadine—Oedema peripheral—Doxorubicin—urinary bladder cancer	0.0019	0.0019	CcSEcCtD
Rimantadine—Asthenia—Etoposide—urinary bladder cancer	0.0019	0.0019	CcSEcCtD
Rimantadine—Chills—Epirubicin—urinary bladder cancer	0.00187	0.00187	CcSEcCtD
Rimantadine—Nausea—Gemcitabine—urinary bladder cancer	0.00184	0.00184	CcSEcCtD
Rimantadine—Vomiting—Cisplatin—urinary bladder cancer	0.00184	0.00184	CcSEcCtD
Rimantadine—Rash—Cisplatin—urinary bladder cancer	0.00182	0.00182	CcSEcCtD
Rimantadine—Dermatitis—Cisplatin—urinary bladder cancer	0.00182	0.00182	CcSEcCtD
Rimantadine—Diarrhoea—Etoposide—urinary bladder cancer	0.00181	0.00181	CcSEcCtD
Rimantadine—Nausea—Fluorouracil—urinary bladder cancer	0.00181	0.00181	CcSEcCtD
Rimantadine—Tinnitus—Doxorubicin—urinary bladder cancer	0.0018	0.0018	CcSEcCtD
Rimantadine—Tension—Epirubicin—urinary bladder cancer	0.00178	0.00178	CcSEcCtD
Rimantadine—Nervousness—Epirubicin—urinary bladder cancer	0.00177	0.00177	CcSEcCtD
Rimantadine—Dizziness—Etoposide—urinary bladder cancer	0.00175	0.00175	CcSEcCtD
Rimantadine—Chills—Doxorubicin—urinary bladder cancer	0.00173	0.00173	CcSEcCtD
Rimantadine—Nausea—Cisplatin—urinary bladder cancer	0.00172	0.00172	CcSEcCtD
Rimantadine—Cough—Methotrexate—urinary bladder cancer	0.0017	0.0017	CcSEcCtD
Rimantadine—Convulsion—Methotrexate—urinary bladder cancer	0.00168	0.00168	CcSEcCtD
Rimantadine—Vomiting—Etoposide—urinary bladder cancer	0.00168	0.00168	CcSEcCtD
Rimantadine—Agitation—Epirubicin—urinary bladder cancer	0.00167	0.00167	CcSEcCtD
Rimantadine—Rash—Etoposide—urinary bladder cancer	0.00167	0.00167	CcSEcCtD
Rimantadine—Dermatitis—Etoposide—urinary bladder cancer	0.00167	0.00167	CcSEcCtD
Rimantadine—Headache—Etoposide—urinary bladder cancer	0.00166	0.00166	CcSEcCtD
Rimantadine—Tension—Doxorubicin—urinary bladder cancer	0.00165	0.00165	CcSEcCtD
Rimantadine—Nervousness—Doxorubicin—urinary bladder cancer	0.00163	0.00163	CcSEcCtD
Rimantadine—Syncope—Epirubicin—urinary bladder cancer	0.00163	0.00163	CcSEcCtD
Rimantadine—Palpitations—Epirubicin—urinary bladder cancer	0.00161	0.00161	CcSEcCtD
Rimantadine—Confusional state—Methotrexate—urinary bladder cancer	0.0016	0.0016	CcSEcCtD
Rimantadine—Loss of consciousness—Epirubicin—urinary bladder cancer	0.0016	0.0016	CcSEcCtD
Rimantadine—Cough—Epirubicin—urinary bladder cancer	0.00159	0.00159	CcSEcCtD
Rimantadine—Convulsion—Epirubicin—urinary bladder cancer	0.00158	0.00158	CcSEcCtD
Rimantadine—Nausea—Etoposide—urinary bladder cancer	0.00157	0.00157	CcSEcCtD
Rimantadine—Hypertension—Epirubicin—urinary bladder cancer	0.00157	0.00157	CcSEcCtD
Rimantadine—Agitation—Doxorubicin—urinary bladder cancer	0.00155	0.00155	CcSEcCtD
Rimantadine—Anxiety—Epirubicin—urinary bladder cancer	0.00154	0.00154	CcSEcCtD
Rimantadine—Hyperhidrosis—Methotrexate—urinary bladder cancer	0.00153	0.00153	CcSEcCtD
Rimantadine—Dry mouth—Epirubicin—urinary bladder cancer	0.00151	0.00151	CcSEcCtD
Rimantadine—Anorexia—Methotrexate—urinary bladder cancer	0.00151	0.00151	CcSEcCtD
Rimantadine—Syncope—Doxorubicin—urinary bladder cancer	0.00151	0.00151	CcSEcCtD
Rimantadine—Confusional state—Epirubicin—urinary bladder cancer	0.0015	0.0015	CcSEcCtD
Rimantadine—Palpitations—Doxorubicin—urinary bladder cancer	0.00149	0.00149	CcSEcCtD
Rimantadine—Loss of consciousness—Doxorubicin—urinary bladder cancer	0.00148	0.00148	CcSEcCtD
Rimantadine—Cough—Doxorubicin—urinary bladder cancer	0.00147	0.00147	CcSEcCtD
Rimantadine—Shock—Epirubicin—urinary bladder cancer	0.00146	0.00146	CcSEcCtD
Rimantadine—Convulsion—Doxorubicin—urinary bladder cancer	0.00146	0.00146	CcSEcCtD
Rimantadine—Hypertension—Doxorubicin—urinary bladder cancer	0.00145	0.00145	CcSEcCtD
Rimantadine—Tachycardia—Epirubicin—urinary bladder cancer	0.00145	0.00145	CcSEcCtD
Rimantadine—Hyperhidrosis—Epirubicin—urinary bladder cancer	0.00143	0.00143	CcSEcCtD
Rimantadine—Insomnia—Methotrexate—urinary bladder cancer	0.00143	0.00143	CcSEcCtD
Rimantadine—Anxiety—Doxorubicin—urinary bladder cancer	0.00143	0.00143	CcSEcCtD
Rimantadine—Anorexia—Epirubicin—urinary bladder cancer	0.00141	0.00141	CcSEcCtD
Rimantadine—Dyspnoea—Methotrexate—urinary bladder cancer	0.00141	0.00141	CcSEcCtD
Rimantadine—Somnolence—Methotrexate—urinary bladder cancer	0.00141	0.00141	CcSEcCtD
Rimantadine—Dry mouth—Doxorubicin—urinary bladder cancer	0.0014	0.0014	CcSEcCtD
Rimantadine—Dyspepsia—Methotrexate—urinary bladder cancer	0.0014	0.0014	CcSEcCtD
Rimantadine—Confusional state—Doxorubicin—urinary bladder cancer	0.00138	0.00138	CcSEcCtD
Rimantadine—Decreased appetite—Methotrexate—urinary bladder cancer	0.00138	0.00138	CcSEcCtD
Rimantadine—Gastrointestinal disorder—Methotrexate—urinary bladder cancer	0.00137	0.00137	CcSEcCtD
Rimantadine—Fatigue—Methotrexate—urinary bladder cancer	0.00137	0.00137	CcSEcCtD
Rimantadine—Shock—Doxorubicin—urinary bladder cancer	0.00135	0.00135	CcSEcCtD
Rimantadine—Insomnia—Epirubicin—urinary bladder cancer	0.00134	0.00134	CcSEcCtD
Rimantadine—Tachycardia—Doxorubicin—urinary bladder cancer	0.00134	0.00134	CcSEcCtD
Rimantadine—Hyperhidrosis—Doxorubicin—urinary bladder cancer	0.00133	0.00133	CcSEcCtD
Rimantadine—Dyspnoea—Epirubicin—urinary bladder cancer	0.00132	0.00132	CcSEcCtD
Rimantadine—Somnolence—Epirubicin—urinary bladder cancer	0.00132	0.00132	CcSEcCtD
Rimantadine—Anorexia—Doxorubicin—urinary bladder cancer	0.00131	0.00131	CcSEcCtD
Rimantadine—Feeling abnormal—Methotrexate—urinary bladder cancer	0.00131	0.00131	CcSEcCtD
Rimantadine—Dyspepsia—Epirubicin—urinary bladder cancer	0.00131	0.00131	CcSEcCtD
Rimantadine—Gastrointestinal pain—Methotrexate—urinary bladder cancer	0.0013	0.0013	CcSEcCtD
Rimantadine—Decreased appetite—Epirubicin—urinary bladder cancer	0.00129	0.00129	CcSEcCtD
Rimantadine—Gastrointestinal disorder—Epirubicin—urinary bladder cancer	0.00128	0.00128	CcSEcCtD
Rimantadine—Fatigue—Epirubicin—urinary bladder cancer	0.00128	0.00128	CcSEcCtD
Rimantadine—Constipation—Epirubicin—urinary bladder cancer	0.00127	0.00127	CcSEcCtD
Rimantadine—Abdominal pain—Methotrexate—urinary bladder cancer	0.00125	0.00125	CcSEcCtD
Rimantadine—Insomnia—Doxorubicin—urinary bladder cancer	0.00124	0.00124	CcSEcCtD
Rimantadine—Dyspnoea—Doxorubicin—urinary bladder cancer	0.00122	0.00122	CcSEcCtD
Rimantadine—Feeling abnormal—Epirubicin—urinary bladder cancer	0.00122	0.00122	CcSEcCtD
Rimantadine—Somnolence—Doxorubicin—urinary bladder cancer	0.00122	0.00122	CcSEcCtD
Rimantadine—Gastrointestinal pain—Epirubicin—urinary bladder cancer	0.00121	0.00121	CcSEcCtD
Rimantadine—Dyspepsia—Doxorubicin—urinary bladder cancer	0.00121	0.00121	CcSEcCtD
Rimantadine—Decreased appetite—Doxorubicin—urinary bladder cancer	0.00119	0.00119	CcSEcCtD
Rimantadine—Gastrointestinal disorder—Doxorubicin—urinary bladder cancer	0.00119	0.00119	CcSEcCtD
Rimantadine—Fatigue—Doxorubicin—urinary bladder cancer	0.00118	0.00118	CcSEcCtD
Rimantadine—Constipation—Doxorubicin—urinary bladder cancer	0.00117	0.00117	CcSEcCtD
Rimantadine—Abdominal pain—Epirubicin—urinary bladder cancer	0.00117	0.00117	CcSEcCtD
Rimantadine—Asthenia—Methotrexate—urinary bladder cancer	0.00114	0.00114	CcSEcCtD
Rimantadine—Feeling abnormal—Doxorubicin—urinary bladder cancer	0.00113	0.00113	CcSEcCtD
Rimantadine—Gastrointestinal pain—Doxorubicin—urinary bladder cancer	0.00112	0.00112	CcSEcCtD
Rimantadine—Abdominal pain—Doxorubicin—urinary bladder cancer	0.00109	0.00109	CcSEcCtD
Rimantadine—Diarrhoea—Methotrexate—urinary bladder cancer	0.00108	0.00108	CcSEcCtD
Rimantadine—Asthenia—Epirubicin—urinary bladder cancer	0.00106	0.00106	CcSEcCtD
Rimantadine—Dizziness—Methotrexate—urinary bladder cancer	0.00105	0.00105	CcSEcCtD
Rimantadine—Diarrhoea—Epirubicin—urinary bladder cancer	0.00102	0.00102	CcSEcCtD
Rimantadine—Vomiting—Methotrexate—urinary bladder cancer	0.00101	0.00101	CcSEcCtD
Rimantadine—Rash—Methotrexate—urinary bladder cancer	0.001	0.001	CcSEcCtD
Rimantadine—Dermatitis—Methotrexate—urinary bladder cancer	0.000999	0.000999	CcSEcCtD
Rimantadine—Headache—Methotrexate—urinary bladder cancer	0.000993	0.000993	CcSEcCtD
Rimantadine—Asthenia—Doxorubicin—urinary bladder cancer	0.000985	0.000985	CcSEcCtD
Rimantadine—Dizziness—Epirubicin—urinary bladder cancer	0.000981	0.000981	CcSEcCtD
Rimantadine—Vomiting—Epirubicin—urinary bladder cancer	0.000943	0.000943	CcSEcCtD
Rimantadine—Nausea—Methotrexate—urinary bladder cancer	0.000942	0.000942	CcSEcCtD
Rimantadine—Diarrhoea—Doxorubicin—urinary bladder cancer	0.000939	0.000939	CcSEcCtD
Rimantadine—Rash—Epirubicin—urinary bladder cancer	0.000935	0.000935	CcSEcCtD
Rimantadine—Dermatitis—Epirubicin—urinary bladder cancer	0.000935	0.000935	CcSEcCtD
Rimantadine—Headache—Epirubicin—urinary bladder cancer	0.000929	0.000929	CcSEcCtD
Rimantadine—Dizziness—Doxorubicin—urinary bladder cancer	0.000908	0.000908	CcSEcCtD
Rimantadine—Nausea—Epirubicin—urinary bladder cancer	0.000881	0.000881	CcSEcCtD
Rimantadine—Vomiting—Doxorubicin—urinary bladder cancer	0.000873	0.000873	CcSEcCtD
Rimantadine—Rash—Doxorubicin—urinary bladder cancer	0.000866	0.000866	CcSEcCtD
Rimantadine—Dermatitis—Doxorubicin—urinary bladder cancer	0.000865	0.000865	CcSEcCtD
Rimantadine—Headache—Doxorubicin—urinary bladder cancer	0.00086	0.00086	CcSEcCtD
Rimantadine—Nausea—Doxorubicin—urinary bladder cancer	0.000815	0.000815	CcSEcCtD
